PHARMATHER INC.
  • Company
    • Management
    • Board of Directors
  • Research
    • Pipeline
    • MN Delivery
    • KETABET
    • panaceAI
    • Patents
  • Investors
  • News
  • Contact

About Us

PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals such as ketamine and psilocybin, for FDA approval to treat mental health, neurological and pain disorders.
Picture
​

Our team includes world-class strategic partners, advisors and a strong leadership team with a proven track record of success in drug development, business development and capital markets.  Our goal is to advance the development of panaceAI™, our drug repurposing artificial intelligence platform, and advance our clinical product pipeline with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.

CONNECT WITH US

© COPYRIGHT 2021.  PharmaTher Inc.   ALL RIGHTS RESERVED.
  • Company
    • Management
    • Board of Directors
  • Research
    • Pipeline
    • MN Delivery
    • KETABET
    • panaceAI
    • Patents
  • Investors
  • News
  • Contact